“…Following the identification of the two SNPs, at least 22 new TAR cases have been reported (Omran et al , ; Bottillo et al , ; Baken et al , ; Idahosa et al , ; Papoulidis et al , ; Reid et al , ; Yassaee et al , ; Al Kaissi et al , ; Kumar et al , ,b; Pereira et al , ; Tassano et al , ; Nicchia et al , ; Jameson‐Lee et al , ). However, the presence of the microdeletion on chromosome 1q21.1 or of the hemizygous SNPs has not been reported in more than half of the described patients (Omran et al , ; Baken et al , ; Idahosa et al , ; Reid et al , ; Al Kaissi et al , ; Kumar et al , ; Pereira et al , ). Many clinical issues of TAR syndrome remain enigmatic: How does the increase in platelet count occur prior to the shift in TPO reactivity in patients' platelets?…”